Growth Metrics

Standard Biotools (LAB) Total Non-Current Liabilities (2016 - 2025)

Standard Biotools (LAB) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $142.2 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 1.93% to $142.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $142.2 million through Dec 2025, up 1.93% year-over-year, with the annual reading at $142.2 million for FY2025, 1.93% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $142.2 million at Standard Biotools, up from $138.8 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $248.3 million in Q1 2022, with the low at $121.5 million in Q1 2025.
  • Average Total Non-Current Liabilities over 5 years is $167.6 million, with a median of $162.4 million recorded in 2022.
  • The sharpest move saw Total Non-Current Liabilities skyrocketed 37.29% in 2022, then crashed 38.48% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $179.7 million in 2021, then fell by 11.22% to $159.6 million in 2022, then decreased by 0.48% to $158.8 million in 2023, then fell by 12.12% to $139.6 million in 2024, then grew by 1.93% to $142.2 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $142.2 million, $138.8 million, and $131.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.